Press release
Imatinib Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Imatinib drug market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to accelerate the growth of the market includes an increase in the prevalence of cancer and an increase in demand for target drug therapy. For instance, according to National Cancer Institute in 2017, the number of new leukemia cases was 62,130 and the number of mortalities was 24,500 which is driving the adoption of the imatinib drug. In addition, the Imatinib drug is used for the treatment of patients with cancer by blocking the growth of eosinophils. This drug has been attributed owing to its higher efficacy in treating Chronic Eosinophilic Leukemia, Hyper-Eosinophilic Syndrome, Gastrointestinal Stromal Tumors (GIST), and many more. However, the high cost of imatinib as compared to several substitutes such as Tarceva, Sprycel, and Tasigna may hamper the market growth.The incidences of chronic eosinophilic leukemia are expected to increase in the future. Chronic eosinophilic leukemia (CEL) is a disorder in which eosinophil count is greater than 1500 µl in peripheral blood also known as hyper-eosinophilia. It is a rare myeloproliferative neoplasm, overproduction of eosinophils in the bone marrow. Imatinib drug is more beneficial in patients who have leukemia from a genetic mutation. Moreover, the Imatinib drug also supports in improving blood counts and symptoms very fast which makes this drug highly adopted by the targeted patient pool. Imatinib for gastrointestinal stromal tumors (GIST) is also showing a significant share as Imatinib has been the first-line therapy for GIST. The drug targets KIT and PDGFRA (platelet-derived growth factor receptor A) proteins blocking the growth of tumor cells.
To Request a Sample of our Report on Imatinib Drug Market: https://www.omrglobal.com/request-sample/imatinib-drug-market-share
Market Coverage
· The market number available for - 2022-2030
· Base year- 2022
· Forecast period- 2023-2030
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Sun Pharmaceutical Industries Ltd., Novartis International AG, and Teva Pharmaceutical Industries Ltd., among others.
Imatinib Drug Market Report by Segment
By Drug Formulation
• Capsules
• Tablets
By Application
• Philadelphia Positive Chronic Myeloid Leukemia
• Myeloproliferative Diseases (MPD)
• Hyper-Eosinophilic Syndrome (HES)
• Myelodysplastic Syndrome (MDS)
• Gastrointestinal Stromal Tumors (GIST)
• Others
A full Report of Imatinib Drug Market is Available at: https://www.omrglobal.com/industry-reports/imatinib-drug-market-share
Imatinib Drug Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
https://www.somosxbox.com.mx/noticias-urgente/el-mercado-de-cubiertas-moviles-sera-testigo-de-un-crecimiento-asombroso-para-2029/120862/
https://perualdia.net/tasa-de-crecimiento-lento-del-mercado-de-cocinas-modulares-previsto-para-2023-2030/
https://ekz-crosstour.ch/news/der-markt-fuer-insektenschutzmittel-wird-bis-2023-2029-ein-starkes-wachstum-verzeichnen/129165/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Imatinib Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here
News-ID: 3204394 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Imatinib
Imatinib Mesylate Drugs Market By Industry Research, Supply, Size, Share and Pro …
The "Imatinib Mesylate Pharmaceuticals Market" 2023 research report offers insight into a global business study with key competitors functioning in the sector and a look at how the market will likely compete in the future. The Imatinib Mesylate Drugs market report created by our experts is a fantastic piece of work that takes into account obstacles and chances while also considering the growth of Imatinib Mesylate Drugs, shares, and revenue…
Imatinib Drug Market Report- Business Review, Technology, Top Companies and Tren …
The Imatinib Drug Market research report studies the competitive development of the Imatinib Drug Market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, Imatinib Drug Market provides a region-wise study of the market, including North America, Asia Pacific, Latin America, Middle East, Africa, and Europe. It helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength,…
Global Imatinib Drug Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global imatinib drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to accelerate the growth of the market includes an increase in the prevalence of cancer and an increase in demand for target drug therapy. For instance, according to National Cancer Institute in 2017, the number of new leukemia cases was 62,130 and the number of mortalities…
Imatinib Drug Market Report: Industry Trends, Size, Revenue, Applications, Typ …
The Imatinib Drug Market is expected to register a CAGR of 3% during the forecast period.
The Global Imatinib Drug Market is predicted to grow significantly over the forecast period. The global incidence of leukaemia, as well as an increase in healthcare professionals' approval of the imatinib drug, are propelling Global Imatinib Drug Market growth. Gastrointestinal Stromal Tumor has seen a significant growth in imatinib demand, and it is projected…
Imatinib Drug Market Growth, Size, Share, Industry Report and Forecast 2020-2026
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…
Imatinib Drug Market Size, Share, Growth, Industry Analysis, Opportunities and F …
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…